Plus Therapeutics CMO Dr. LaFrance Resignation Announced
Company Announcements

Plus Therapeutics CMO Dr. LaFrance Resignation Announced

Plus Therapeutics (PSTV) has shared an update.

Plus Therapeutics, Inc. is set to experience a change in its executive team as Dr. Norman LaFrance, the Chief Medical Officer, has tendered his resignation, which will take effect on June 12, 2024.

Find detailed analytics on PSTV stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyPlus Therapeutics, SpectronRx announce manufacturing partnership
Austin AngeloPSTV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
TheFlyPlus Therapeutics files $100M mixed securities shelf
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App